KCNMA1 sirna
KCNMA1 siRNA (Rat)
NCBI and Uniprot Product Information
NCBI Description
large-conductance Ca(2+)-activated K(+) channel; may be involved in the shortened duration of action potential in hippocampal CA1 pyramidal neurons and in channel activity in carotid body chemoreceptor cells [RGD, Feb 2006]
Uniprot Description
KCNMA1: Potassium channel activated by both membrane depolarization or increase in cytosolic Ca(2+) that mediates export of K(+). It is also activated by the concentration of cytosolic Mg(2+). Its activation dampens the excitatory events that elevate the cytosolic Ca(2+) concentration and/or depolarize the cell membrane. It therefore contributes to repolarization of the membrane potential. Plays a key role in controlling excitability in a number of systems, such as regulation of the contraction of smooth muscle, the tuning of hair cells in the cochlea, regulation of transmitter release, and innate immunity. In smooth muscles, its activation by high level of Ca(2+), caused by ryanodine receptors in the sarcoplasmic reticulum, regulates the membrane potential. In cochlea cells, its number and kinetic properties partly determine the characteristic frequency of each hair cell and thereby helps to establish a tonotopic map. Kinetics of KCNMA1 channels are determined by alternative splicing, phosphorylation status and its combination with modulating beta subunits. Highly sensitive to both iberiotoxin (IbTx) and charybdotoxin (CTX). Defects in KCNMA1 are the cause of generalized epilepsy and paroxysmal dyskinesia (GEPD). Epilepsy is one of the most common and debilitating neurological disorders. Paroxysmal dyskinesias are neurological disorders characterized by sudden, unpredictable, disabling attacks of involuntary movement often requiring life-long treatment. The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family is an increasingly recognized phenomenon. Patients manifest absence seizures, generalized tonic-clonic seizures, paroxysmal nonkinesigenic dyskinesia, involuntary dystonic or choreiform movements. Onset is usually in childhood and patients may have seizures only, dyskinesia only, or both. Belongs to the potassium channel family. Calcium- activated (TC 1.A.1.3) subfamily. KCa1.1/KCNMA1 sub-subfamily. 7 isoforms of the human protein are produced by alternative splicing.
Protein type: Endoplasmic reticulum; Membrane protein, integral; Channel, potassium; Membrane protein, multi-pass
Cellular Component: voltage-gated potassium channel complex; endoplasmic reticulum membrane; protein complex; endoplasmic reticulum; cell; dendrite; integral to membrane; terminal button; caveola; postsynaptic membrane; cell soma; perinuclear region of cytoplasm; cytoplasm; apical plasma membrane; plasma membrane; presynaptic active zone membrane; external side of plasma membrane
Molecular Function: protein binding; voltage-gated potassium channel activity; calcium-activated potassium channel activity; protein homodimerization activity; potassium channel activity; metal ion binding; large conductance calcium-activated potassium channel activity; protein complex binding; actin binding
Biological Process: circadian rhythm; relaxation of vascular smooth muscle; regulation of vasodilation; positive regulation of apoptosis; cell maturation; generation of action potential; auditory receptor cell differentiation; vasodilation; cellular potassium ion homeostasis; adult walking behavior; response to corticosteroid stimulus; protein homotetramerization; locomotor rhythm; synaptic transmission; sensory perception of sound; neuromuscular process controlling balance; potassium ion transport; protein homooligomerization; regulation of aldosterone metabolic process; eye blink reflex; response to osmotic stress; micturition; regulation of membrane potential; response to estrogen stimulus; smooth muscle contraction involved in micturition; response to hypoxia; response to calcium ion; negative regulation of cell volume; saliva secretion; response to pH
Research Articles on KCNMA1
Similar Products
Product Notes
The KCNMA1 kcnma1 (Catalog #AAA827870) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The KCNMA1 siRNA (Rat) reacts with Rat and may cross-react with other species as described in the data sheet. AAA Biotech's KCNMA1 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the KCNMA1 kcnma1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "KCNMA1, siRNA" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.